Objectives: To determine whether body fat distribution, measured by waist circumference (WC) and waist/hip ratio (WHR), is a better predictor of mortality and morbidity after colorectal surgery than body mass index (BMI) or body surface area (BSA). Background: Obesity measured by BMI is not a consistent risk factor for postoperative mortality and morbidity after abdominal surgery. Studies in metabolic and cardiovascular diseases have shown WC and WHR to be better outcome predictors than BMI. Methods: A prospective multicenter international study was conducted among patients undergoing elective colorectal surgery. The WHR, BMI, and BSA were derived from body weight, height, and waist and hip circumferences measured preoperatively. Uni-and multivariate analyses were performed to identify risk factors for postoperative outcomes. Results: A total of 1349 patients (754 men) from 38 centers in 11 countries were included. Increasing WHR significantly increased the risk of conversion [odds ratio (OR) = 15.7, relative risk (RR) = 4.1], intraoperative complications (OR = 11.0, RR = 3.2), postoperative surgical complications (OR = 7.7, RR = 2.0), medical complications (OR = 13.2, RR = 2.5), anastomotic leak (OR = 13.7, RR = 3.3), reoperations (OR = 13.3, RR = 2.9), and death (OR = 653.1, RR = 21.8). Both BMI (OR = 39.5, RR = 1.1) and BSA (OR = 4.9, RR = 3.1) were associated with an increased risk of abdominal wound complication. In multivariate analysis, the WHR predicted intraoperative complications, conversion, medical complications, and reinterventions, whereas BMI was a risk factor only for abdominal wall complications; BSA did not reach significance for any outcome. Conclusions: The WHR is predictive of adverse events after elective colorectal surgery. It should be used in routine clinical practice and in future risk-estimating systems.
O verweight [body mass index (BMI) = 25 to <30 kg/m 2 ] and obesity (BMI ≥30 kg/m 2 ) are pandemic conditions. The most recent data from the United States show that 40% of adult men and 30% of women fall within the overweight category. The prevalence of obesity is increasing and significantly influences overall survival of the general population. 1 Although BMI, approximating body fat percentage, has been the most popular measurement of obesity, recent studies have promoted new measurements of obesity that reflect body fat distribution.
The INTERHEART study found that abdominal obesity, defined by increased waist circumference (WC) and waist/hip ratio (WHR), was predictive of risk of myocardial infarction whereas BMI was not significantly associated. 2, 3 A further prospective study identified WHR as a better predictor of death after myocardial infarction than BMI. 4 Both WC and hip circumference (HC) and their ratio and body surface area (BSA) are the most frequently cited alternatives to BMI. In a large sample of the European population, both general adiposity, measured by BMI, and abdominal adiposity, expressed by WC and WHR, were found to be associated with increased death rate. Therefore, the combined use of these indicators in assessing the risk of death was advocated. 5 Although many surgeons suspect that obesity negatively influences outcomes after abdominal surgery, well-designed studies have been unable to show that obesity is an independent risk factor for major morbidity or mortality after general abdominal surgery. [6] [7] [8] Studies specific to colorectal surgery have confirmed these observations. [9] [10] [11] However, these studies may have used an inappropriate measure of obesity. Indeed, abdominal obesity, measured by WC and WHR, may be a better predictor of adverse outcome after abdominal surgery than BMI. Therefore, the aim of our study was to answer the following question: Are WC and WHR better predictive risk factors than BMI or BSA to assess the impact of obesity on mortality and morbidity after colorectal surgery?
PATIENTS AND METHODS
A prospective multicenter international study was conducted involving 38 colorectal surgery units from 11 countries. Patients undergoing elective colorectal resection by either open approach or laparoscopic approach for colorectal cancer, polyps, polyposis, volvulus, and diverticular disease were included during the period from November 2008 to December 2009. Exclusion criteria were as follows: patient age less than 18 years, inability to give informed consent, emergency surgery, pregnancy, and comorbidity resulting in altered abdominal circumference measurement (ascites secondary to chronic liver disease, peritoneal carcinomatosis, intestinal obstruction, abdominal mass lesions >20 cm of diameter on computed tomographic scan, preexisting abdominal stoma, incisional hernia). Patients with inflammatory bowel disease were also excluded because this group carries an increased risk of adverse outcomes such as venous thromboembolism.
Height, weight, WC, and HC were recorded for each patient in addition to routine patient demographic data regarding comorbidities, diagnosis, operative data, and postoperative morbidity and mortality.
Data were stored in a database designed for this study with online/offline data submission for each participating center. The central database was managed by an independent data management center (Data Management System S.A., Brussels, Belgium) and reviewed regularly for inconsistencies and missing data. Centers were contacted by e-mail or phone when such problems were detected.
Measurement of Anthropometric Parameters
BMI was calculated as weight in kilograms divided by height in meters squared. The World Health Organization terminology for BMI classification was used: underweight (BMI <18.5), normal weight (BMI 18.5 to <25), overweight (BMI 25 to <30), obesity (BMI ≥30), including obesity classes I (30 to <35), II (35 to <40), and III (≥40).
12
WC was measured with the patient standing during end expiration, with unclothed abdomen at the midpoint between the lower costal margin and the top of the iliac crest with a horizontal tape measure and without compression of the skin (Fig. 1) . The Lean classification was used: normal (<94 cm in men and <80 cm in women), low risk (94-102 cm in men and 80-88 cm in women), and high risk (>102 cm in men and >88 cm in women). 13 HC was measured with the patient standing lightly clothed, measured with a horizontal tape measure at the largest circumference over the buttocks.
To ensure proper measurements of WC and HC, written guidelines explaining the correct way to proceed step by step were sent to all local investigators. Measurements were recorded in duplicate to the nearest 0.5 cm. If the difference between the 2 measurements was greater than 2 cm, a third measurement was taken and the mean of the 2 closest measurements was recorded. Although, ideally, the measurements should be taken independently by 2 observers, in fact, there are data showing that these measurements are highly reproducible (r >0.99) and that measurement by a single observer is acceptable. 14 The WHR was calculated according to the following formula: WC (cm)/HC (cm). Thresholds for WHR of 1.0 in men and 0.85 in women were used to define abdominal obesity. 15 
Outcome Measures
The main outcome measures were in-hospital mortality, intraoperative complications and conversion from laparoscopy to open surgery, and in-hospital postoperative medical and surgical morbidity, with particular emphasis on anastomotic leak (for procedures including an anastomosis), reoperation, and abdominal wall FIGURE 1. A measuring tape is placed around the trunk, at a point midway between the lower costal margin and the iliac crest, while the patient is standing. WC is recorded to the nearest 0.5 cm at the end of a normal expiration. HC is measured at the widest point over the greater trochanters. complications. In this study, the term "abdominal wall complications" refers to surgical site infection (SSI), that is, infection of the superficial or deep tissues of the surgical incision, in addition to superficial wound dehiscence and evisceration.
Statistical Analysis
The likelihood ratio test (and the Fisher exact test, where appropriate) was used to assess the statistical significance of an association between BMI, WC, WHR, BSA, and the outcome measures. Predictions for the risk of complication were analyzed using logistic regression models, adjusted for the 4 anthropometric markers. Corresponding relative risk (RR) and odds ratio (OR) were reported. The results of univariate analysis were used to identify candidate variables to create stepwise backward multivariate logistic regression models. Area under the curve and generalized R 2 statistics were used to assess performance of the models. When not otherwise specified, the anthropometric variables were tested as continuous variables.
All P values were 2-tailed, and P values of less than 0.05 were considered statistically significant. Analysis was performed using JMP software (version 10) and SAS software (version 9.3; SAS Institute Inc, Cary, NC).
Ethical Committee Approval
This study was conducted in conformity with the Declara- 
Study Registration
This clinical trial has been registered in the ClinicalTrials.gov online database: registration number NCT01737515.
RESULTS

Patient-and Surgery-Related Characteristics
A total of 1349 patients (mean age: 64.8 years ± 13.2; 754 men), from 38 centers in 11 countries, who underwent elective colorectal surgery were included in this prospective multicenter study. Patient demographics and diagnostic and operative characteristics are shown in Table 1 . According to International Diabetes Federation definitions, 687 patients (50.9%) had metabolic syndrome. 17 The majority of patients (n = 978; 72.5%) were operated on for colorectal cancer [colon (n = 559; 57.2%); rectum (n = 419; 42.8%)]. Patients included in the present study underwent a wide range of colorectal surgical procedures, with a laparoscopic approach used in 56.4%. Only 150 patients (11%) were enrolled in an enhanced recovery program.
Anthropometric data are given in Table 2 . More than half of the patients (54.6%) were overweight (ie, BMI >25). In 645 patients (47.1%), WC exceeded the threshold for at-risk obesity (men: >102 cm; women: > 88 cm) and 730 patients (54.1%) had a high-risk WHR (men: >1.0; women: >0.88).
Operative Data
Intra-and postoperative data are summarized in Table 3 . A majority of patients (56.4%) underwent laparoscopic surgery, with a conversion rate of 12.7%. Intraoperative adverse events occurred in 204 patients (15.1%). patients (6.4%), and 67 patients (5.0%) experienced an abdominal wall complication including SSI (Table 3) . Using univariate analysis with 46 variables tested, 17 were potential risk factors for intraoperative complications, 6 for conversion, 19 for global morbidity, 17 for medical complications, 13 for surgical complications, 6 for anastomotic leak, 4 for repeat surgery, and 14 for abdominal wall surgery (Table 4) .
There was a significant relationship between WHR and all 9 outcomes, with an RR of 1.8 (1.2-2.8) for overall morbidity and an RR of 3.2 (1.8-5.9) for intraoperative complications. ORs ranged from 7.7 for surgical postoperative complications to 15.7 for the conversion rate in laparoscopic surgery (Table 5 ). In contrast, both BMI and BSA were found to be associated only with abdominal wall complications.
After stepwise backward multivariate logistic regression, 12 variables were retained as risk factors for 1 or more intra-or postoperative outcomes (Table 6 ). Although WHR was significantly associated with mortality in the univariate analysis, this outcome was excluded from the multivariate analysis because of the low number of events (n = 9; 0.7%). The most frequently involved variables were male sex, increased WHR, perioperative blood transfusion, and abdominal drainage.
A special focus on the anthropometric risk factors related to obesity resulted in WHR as an independent risk factor for intraoperative complications, conversion from a laparoscopic approach to an open approach, medical complications, and reoperation. Both WC and BMI were predictors for surgical postoperative complications and abdominal wall complications, respectively. BMI had some protective effect on medical complications, whereas BSA had a protective effect on the occurrence of postoperative complications. 
Abdominal Wall Complications
Age P < 0.02 P < 0.001 P < 0.0001 P < 0.05 Sex (male) P < 0.01 P < 0.002 P < 0.01 P = 0.001 P < 0.02 Comorbidity P = 0.002 P = 0.0002 P < 0.0001 P < 0.05 No. comorbidities P < 0.001 P < 0.0001 P < 0.0001 P < 0.05 P = 0.001 Cirrhosis P < 0.02 P < 0.02 COPD P < 0.0001 P < 0.02 P < 0.05 Diabetes P < 0.0001 P < 0.0001 P < 0.05 Type 1 Type 2 Metabolic syndrome * P < 0.005 P < 0.05 P < 0.05 P < 0.05 Ischemic heart disease P < 0.05 P < 0.0001 Neurological disorders P < 0.02 P < 0.002 Pulmonary embolism P < 0.02 Smoker P < 0.005 Weight loss >10% ASA score P < 0.0001 Pathology Cancer P < 0.02 P < 0.02 P < 0.001 Tumor location P < 0.002 P < 0.0001 P < 0.005 P < 0.002 Diverticulitis P < 0.02
05 Previous abdominal surgery Bowel preparation P < 0.005 P < 0.005 P < 0.05 P < 0.002 Surgical approach ‡ P < 0.002 P < 0.01 P < 0.05 Surgical procedures P < 0.01 P < 0.0001 P < 0.0001 P < 0.0001 P < 0.002 Anastomosis P < 0.01 Diverting stoma P < 0.05 P < 0.005 P < 0.01 En bloc resection P < 0.01 No. organs P < 0.002 Blood transfusion P < 0.0001 P < 0.0002 P < 0.0005 P < 0.002 P < 0.0005 No. blood transfusions Abdominal drainage P < 0.0005 P < 0.0001 P < 0.05 P = 0.0001 P < 0.005 P < 0.02 ERAS P < 0.02 P < 0.05 * According to the International Diabetes Federation definition. 17 †Anthropometric measures have been tested as continuous variables. ‡Surgical approach: laparotomy versus laparoscopy (including conversion). ASA indicates American Society of Anesthesiology; COPD, chronic obstructive pulmonary disease; ERAS indicates enhanced recovery after surgery.
DISCUSSION
This prospective, multicenter, international study of patients who underwent colorectal surgery shows that WHR is superior to BMI or WC in predicting important surgical outcomes, including intraoperative complications, conversion from the laparoscopic approach to the open approach, medical complications, and reoperation.
Thus, the previous failure to prove the long-held suspicion of many surgeons that obesity carries an increased risk of adverse outcomes may be explained simply: previous studies used inappropriate measurement of obesity. To our knowledge, this is the first study to examine the impact of abdominal (central) obesity, as defined by WHR and WC, on outcomes of abdominal surgery. Hence, there is little surgical literature with which to compare our results. Previous studies have shown an association between BMI and wound complications, an observation supported by this study. 7, 18, 19 One might expect increased postoperative morbidity in obese patients because they often have the worse American Society of Anesthesiology score or more preexisting comorbid illnesses, including diabetes, hypertension, cardiovascular disease, and lipid disorder. 20 Moreover, obesity might increase technical difficulty and thus operative time in laparoscopic surgery. 18 However, almost all previous studies examining the impact of obesity on conversion from a laparoscopic approach to an open approach and postoperative morbidity and mortality have used BMI-based definitions, and, in most studies, no association could be observed. [6] [7] [8] [9] [10] 20, 21 Although BMI was found to be 1 of the 3 most important factors influencing postoperative outcome after colorectal surgery in a large series of 3552 patients, BMI-defined obesity has not been consistently featured as an independent predictor of risk in any large prospective analysis. [22] [23] [24] [25] [26] [27] The data in this study are robust: All centers in this study specialize in colorectal surgery, which is reflected by the low mortality rate of 0.7% and the overall morbidity rate of 26.2% in accordance with the 24.3% rate published by Cohen et al 26 in a data set of 28,863 colorectal procedures.
In our univariate logistic regression model, the WHR showed an RR of 3.3 for mortality. However, it had to be excluded as a 
<0.002
The 4 anthropometric variables have been tested as continuous variables. ERAS indicates enhanced recovery after surgery.
potential candidate from the multivariate analysis because of the very low number of deaths (n = 9; 0.7%). In that respect, the present study needs to be confirmed in a larger cohort of patients. Regarding laparoscopic surgery, the rate of conversion reported in the literature ranges widely from 11% to 39%. 21 Data from the UK CLASICC (Conventional versus Laparoscopic-Assisted Surgery In Colorectal Cancer) trial found that BMI was an independent risk factor for conversion to open surgery in rectal and colon cancer resection, 28 whereas the Cleveland Clinic has reported increased conversion rates and morbidity among obese patients undergoing laparoscopic colectomy. 29, 30 In a recent meta-analysis, the conversion rate varied from 1.1% to 18.0% in nonobese patients and from 0% to 45.8% in obese patients. 20 The common reasons for conversion were exposure problems and dissection difficulties. In a comparative study between obese and nonobese patients, Pikarsky et al 31 have shown that the reason for conversion in the obese group was more likely to be poor visualization secondary to intra-abdominal fat or bleeding whereas the most likely reason for conversion in the nonobese group was adhesions. Because WHR is a more specific indicator for visceral intra-abdominal fat, it was expected to be a strong risk factor for conversion. In the present study, the WHR had an RR of 4.1, an OR of 15.7 in the univariate logistic regression model, and a high significance in the multivariate model for conversion.
As far as reoperations are concerned, among 9 comparative studies, only one reported a significantly increased reoperation rate in obese patients after laparoscopic surgery, whereas authors of other studies observed no statistically significant difference in the overall reoperation rate between obese (0%-18.2%) and nonobese (0%-8.6%) patients. 20 Again, in the present study, an increased WHR was related to an increased risk of reoperation (OR = 13.3, RR = 2.9) in univariate analysis, remaining statistically significant after multivariate logistic regression.
Obesity, defined by BMI, has been validated as a risk factor for SSIs, with some reports demonstrating an increased risk of SSI as high as 60% among obese patients. 7, 19, 20, 32, 33 WC is thought to reflect abdominal adiposity, including subcutaneous fat layer, and intra-abdominal visceral adiposity. Therefore, it was expected to be a risk factor for both surgical complications and abdominal wall complications, including wound infection. However, although using WC, the OR was 31.4 and RR was 1.01 for SSI in univariate logistic regression analysis, it did not reach statistical significance in the multivariate model. Why WC does not seem to be a risk factor for SSI in this study remains unclear and requires further large-scale studies.
In our study, increasing BSA seemed to favorably influence the rate of complications for unknown reasons. This contrasts with the findings of Vaccaro et al, 34 who in a series of 916 consecutive patients, showed that BSA of 1.8 m 2 or more led to a higher conversion rate and operative time.
Besides anthropometric factors, male sex, abdominal drainage, and blood transfusion were independent predictors for a number of main outcomes in the multivariate analysis. Two systematic reviews of abdominal drainage have shown no evidence of benefit on mortality, anastomotic leakage, wound infection, or other major complications. 35, 36 However, the conclusions were based on methodologically poor studies and should be interpreted with caution. In the present study, at least 27.5% of anastomoses were rectal. This percentage differs from the ones reported in systematic reviews. This difference might explain the observed significant prognostic value of drainage.
Conversely, our findings concerning blood transfusion support published data. 37, 38 The predictive value of male sex for morbidity and, more specifically, for anastomotic leakage in our study confirms previous results based on a very large series. Possible explanations for these findings include the difficulty of achieving satisfactory anastomosis within the narrow male pelvis in restorative rectal resection. 39, 40 In the future, our data about WC and WHR have to be compared with other modalities currently proposed to measure fat. Indirect measurement can be done through dual-energy x-ray absorptiometry, ultrasonography, and bioelectric impedance. Direct measurement may include computed tomography and magnetic resonance imaging. An ideal measurement method should be noninvasive with no or limited radiation exposure, reliable with low variability, suitable for all body sizes, broad in availability, and time-and cost-effective. 41 
CONCLUSIONS
This study demonstrates the usefulness of WHR in predicting intraoperative adverse events, conversion from laparoscopic to open surgery, medical postoperative complications, and the need for reoperation after colorectal surgery. WC may also be useful for predicting postoperative surgical complications. In contrast, BMI is of limited use, predicting only abdominal wall complications.
These findings will need to be confirmed using a large series of data from various institutions. A validation study of the present results is currently under way with the objectives of finding cutoff values of WC and WHR not only for morbidity but also for mortality after colorectal surgery. In conclusion, the use of WC and WHR should be further explored for better risk estimation in clinical practice.
DISCUSSANTS P. Ronan O'Connell (Dublin, Ireland):
I would like to thank the association for the opportunity to comment on this article. In an age of increasing complexity and cost, it really is refreshing to hear that simple measurements such as WC and WHR are predictive of intra-and postoperative complications. I would like to congratulate the authors for conducting such a large study that includes patients from 11 countries, 38 centers, and 60 surgeons. In 1 year, you were able to obtain information on 1349 patients who underwent elective colorectal resection. However, if you explore these data, you find that given the large number of centers concerned, this actually equates to only 30 patients per center. We know that many of the centers are high volume, some of them doing 100 or even 200 colorectal resections per year. So, does this raise concern regarding the study design and the potential for selective patient recruitment? How was the sample size determined, did you do some form of power calculation, and how confident can you be that the study cohort represents a representative sample of the patient populations in the individual institutions that partook?
Now quite apart from the anthropometric data, the surgical outcomes are extraordinarily good, even accepting they are reported from institutions with specialized colorectal interest. The overall mortality of less than 1%, surgical morbidity of less than 18%, and abdominal wall complication rate of 5% are exceptionally low. Could it be that these outstanding results are again related to selection inclusion of patients, or could it be that the follow-up of these patients was incomplete?
In that regard, the wound infection rate is truly very low for colorectal resection. Data from my own unit show that the superficial wound infection rate was 7% at time of hospital discharge, but if you did a detailed 30-day follow-up on these patients, it doubled. How confident are you that the data you present are robust? Was there careful follow-up of these patients after they had been discharged such that we actually know that the data presented are real in terms of the complication rates?
The last point is that I would like to know how you feel the anthropometric data might be used to alter surgical practice. It would seem that even if WC can predict higher laparoscopic conversation rate and greater overall surgical complication rate, it is not a variable that we can modify in the short term. When faced with a patient with colorectal cancer or symptomatic diverticular disease, it is not immediately apparent to me how the information might be used to improve patient care. Thank you.
Reply From A.H. Kartheuser (Brussels, Belgium):
Thank you very much for these comments and of course you raised a very important question concerning the validity of the data. Regarding the study design, we did not have any preexisting data about WC and WHR related to colorectal surgery in the literature, so this is a preliminary study that opens the way for many other studies. We did not have a comparison between BMI and WHR, so we had a lot of discussion with our statistician and we decided that it was impossible to make a power calculation. So, we decided to go for more than a thousand to have a population as big as we can. That is why the study took quite a while.
The second one is about surgeon compliance and bias. Of course, there can be a bias, but we think it is unlikely, as there are no data favoring one anthropometric measure or the other. may not include the worst patient or the major complication, but it should not impact what we were looking at and that was the impact on morbidity of waist, hip, and WHR.
One of the authors did the data collection for the 4 major centers and collected more than 25% of the data. Six centers collected more than 50% of patients' data, so for these centers we are quite confident about the inclusion rate, but, of course, for small centers, it is quite difficult to be completely sure that we do not have any bias.
Regarding how to use the information, for benign disease, we can of course give advice regarding weight loss, but we need further study to find the optimum values of WC and WHR for use in the clinical practice. For patients with cancer, we cannot change anything; we can just counsel the patient and say you are in risk category and these are the risks. This is a very simple, very easy, and a very cheap way; just a tape to have maybe a good risk factor and a very easy formula, if it is like all the score factors such as the bottom score, if it is not easy to use, people will not use it. This is very simple measurement and very easy to use.
DISCUSSANTS D.A. Legemate (Amsterdam, The Netherlands):
Just one brief question, you did not stratify in your analysis and your study design for patients operated on for cancer and those operated on for inflammation. Would not that be useful to do?
Reply From A.H. Kartheuser (Brussels, Belgium):
I think that the first point regarding inflammation, we just included diverticulitis and elective surgery for diverticulitis but not inflammatory bowel disease. This is a global population study, but of course what you say is very important, to look at subgroups: cancer versus noncancer, or colon cancer versus rectal cancer, or laparoscopy approach versus open approach, or male versus female sex. This has to be done, but I am afraid that if you look at the subgroups, we do not have sufficient numbers. So, this is again an opening for further studies. Thank you.
